Related Experiment Video
Updated: Sep 1, 2025
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.4K
Cardiomyopathies in the Clinical Practice - an Overview
Lukas P Schulz1, Annina S Vischer2
1Department of Cardiology, University Hospital Basel, Basel, Switzerland.
Praxis
|August 17, 2022
Summary
Cardiomyopathies involve heart muscle abnormalities. This review covers hypertrophic (HCM), dilated (DCM), and arrhythmogenic (ACM) cardiomyopathies, detailing their causes, diagnosis, and treatments.
Area of Science:
- Cardiology
- Internal Medicine
- Genetics
Background:
- Cardiomyopathies are diseases of the heart muscle.
- These disorders lead to structural and functional heart abnormalities.
- Hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and arrhythmogenic cardiomyopathy (ACM) are the most prevalent forms.
Purpose of the Study:
- To provide a comprehensive overview of HCM, DCM, and ACM.
- To detail the pathophysiology, clinical presentation, and diagnostic approaches for these cardiomyopathies.
- To discuss risk stratification and current therapeutic strategies.
Main Methods:
- Literature review of pathophysiological aspects.
- Analysis of clinical presentation and diagnostic criteria.
- Synthesis of risk stratification and treatment modalities.
Main Results:
- Detailed description of the distinct features of HCM, DCM, and ACM.
- Emphasis on the importance of accurate diagnosis and risk assessment.
- Overview of evolving therapeutic concepts for managing cardiomyopathies.
Conclusions:
- Effective management of cardiomyopathies requires understanding their specific pathophysiological underpinnings.
- Integrated diagnostic and risk stratification approaches are crucial.
- Tailored therapeutic strategies improve patient outcomes in HCM, DCM, and ACM.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
46
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
46
01:29Cardiomyopathy V: Interprofessional Care
29
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
40
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
40
01:30Cardiomyopathy II: Dilated Cardiomyopathy
19
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
01:29Cardiomyopathy VI: Nursing Management
28
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
28
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
22
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
22